BACKGROUND: Monocyte chemoattractant protein-1 (MCP-1), a potent chemoattractant for monocytes, plays an important role in the earliest events of atherogenesis. However, direct evidence of the effects of MCP-1 on atherosclerosis in chronic hemodialysis (HD) patients has not been reported. METHODS AND RESULTS: The serum MCP-1 concentrations and the intimal - medial thickness (IMT) in the carotid arteries were measured in 42 non-diabetic chronic HD patients and 20 age-matched controls. The expression of MCP-1 was examined immunohistochemically in radial arterial tissues obtained from the HD patients. IMT and the serum concentration of MCP-1 in the HD patients were both significantly greater than in controls. Multiple regression analysis revealed that the serum concentration of MCP-1 was an independent factor influencing IMT. Tissue immunostaining showed that MCP-1 is expressed in both endothelial and smooth muscle cells and that its level of expression correlates with the serum concentration of MCP-1. CONCLUSIONS: An increase in MCP-1 may be an important factor in the progression of atherosclerosis in non-diabetic HD patients.
BACKGROUND:Monocyte chemoattractant protein-1 (MCP-1), a potent chemoattractant for monocytes, plays an important role in the earliest events of atherogenesis. However, direct evidence of the effects of MCP-1 on atherosclerosis in chronic hemodialysis (HD) patients has not been reported. METHODS AND RESULTS: The serum MCP-1 concentrations and the intimal - medial thickness (IMT) in the carotid arteries were measured in 42 non-diabetic chronic HDpatients and 20 age-matched controls. The expression of MCP-1 was examined immunohistochemically in radial arterial tissues obtained from the HDpatients. IMT and the serum concentration of MCP-1 in the HDpatients were both significantly greater than in controls. Multiple regression analysis revealed that the serum concentration of MCP-1 was an independent factor influencing IMT. Tissue immunostaining showed that MCP-1 is expressed in both endothelial and smooth muscle cells and that its level of expression correlates with the serum concentration of MCP-1. CONCLUSIONS: An increase in MCP-1 may be an important factor in the progression of atherosclerosis in non-diabeticHDpatients.
Authors: John P Cullen; Shariq Sayeed; Ying Jin; Nicholas G Theodorakis; James V Sitzmann; Paul A Cahill; Eileen M Redmond Journal: Am J Physiol Heart Circ Physiol Date: 2005-05-20 Impact factor: 4.733
Authors: L Parker Gregg; Maria Clarissa Tio; Xilong Li; Beverley Adams-Huet; James A de Lemos; S Susan Hedayati Journal: Am J Nephrol Date: 2018-06-06 Impact factor: 3.754
Authors: Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin Journal: Biochim Biophys Acta Mol Basis Dis Date: 2016-12-01 Impact factor: 5.187
Authors: Gi Soo Kang; Patricia Anne Gillespie; Albert Gunnison; Andre Luis Moreira; Kam-Meng Tchou-Wong; Lung-Chi Chen Journal: Environ Health Perspect Date: 2010-09-22 Impact factor: 9.031
Authors: Patrick H Dessein; Ahmed Solomon; Angela J Woodiwiss; Gavin R Norton; Linda Tsang; Miguel A Gonzalez-Gay Journal: Mediators Inflamm Date: 2013-12-21 Impact factor: 4.711